TGFB1 and prostate carcinoma: A study by Huang et al. [17] demonstrated that miR-582-3p and miR-582-5p simultaneously inhibit multiple components of the TGF-β signaling pathway, regulating TGF-β signaling and inhibiting prostate cancer bone metastasis.